August 11, 2025 - 19:09

Tempest has made notable progress in its oncology pipeline, receiving clearance to initiate a pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in China. This advancement marks a critical step in the quest to provide effective treatment options for patients battling this aggressive form of liver cancer.
In addition to the trial clearance in China, the company has been granted orphan drug designation by the European Medicines Agency (EMA) for amezalpat, further highlighting the therapy's potential in addressing unmet medical needs for HCC patients. This designation is crucial as it provides various incentives to expedite the development and review of the drug.
At the recent 2025 AACR Annual Meeting, Tempest presented new data on the mechanism of action of amezalpat, reinforcing its promise as a novel cancer treatment. Furthermore, the FDA has granted orphan drug designation for TPST-1495, aimed at treating familial adenomatous polyposis, showcasing the company's commitment to advancing therapies for rare diseases.
November 19, 2026 - 23:09
Webull Announces Financial Results for Q3 2026Webull Corporation reported its financial and operational results for the third quarter ending September 30, 2026. The Company showcased a robust performance, reflecting its commitment to enhancing...
November 19, 2026 - 10:57
Goldman Sachs Invests $280 Million in Payhawk's Finance Operating SystemGoldman Sachs has taken a significant step in the fintech arena by leading a funding round of $280 million for Payhawk. This investment aims to enhance Payhawk`s global Finance Operating System,...
November 18, 2026 - 20:28
Urgent Need for Social Security Reform as Financial Issues EscalateDecades of political gridlock over entitlement reforms are coming to a head as Congress confronts a dwindling opportunity to avert significant cuts to Social Security benefits. The program, which...
November 18, 2026 - 01:16
Austin Peay State University to Present Documentary "This Is Not Financial Advice"Austin Peay State University will host a screening of the documentary `This Is Not Financial Advice` on December 1. This film delves into the complexities of financial literacy and the often murky...